Molecular genetics of drug-resistant Mycobacterium tuberculosis isolates in Finland, 1995-2004

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 3, 2008, Pages 338-343

  Marttila, Harri J ^a   Makinen J ^a   Marjamaki M ^a   Ruutu, P ^a   Soini, H ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Drug resistance; Molecular epidemiology; Mutations; Mycobacterium tuberculosis; Nationwide survey

Indexed keywords

ISONIAZID; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CLUSTER ANALYSIS; DISEASE TRANSMISSION; DRUG SENSITIVITY; FINLAND; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENOTYPE; MOLECULAR EPIDEMIOLOGY; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; MUTATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SCREENING; TIME SERIES ANALYSIS; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, BACTERIAL; FINLAND; GENOTYPE; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; POINT MUTATION; RIFAMPIN; SEROEPIDEMIOLOGIC STUDIES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 40549117174     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35: 907-914.
2. Supply P, Allix C, Lesjean S, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2006; 44: 4498-4510.
3. van Embden J D, Cave M D, Crawford J T, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-409.
4. Cox H S, Kubica T, Doshetov D, Kebede Y, Ruesch-Gerdes S, Niemann S. The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia. Respir Res 2005; 6: 134.
5. Herrera L, Jimenez S, Valverde A, Garcia-Aranda M A, Saez-Nieto J A. Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). Description of new mutations in the rpoB gene and review of the literature. Int J Antimicrob Agents 2003; 21: 403-408.
6. Kubica T, Rüsch-Gerdes S, Niemann S. The Beijing genotype is emerging among multidrug-resistant Mycobacterium tuberculosis strains from Germany. Int J Tuberc Lung Dis 2004; 8: 1107-1113.
7. Pfyffer G E, Strassle A, van Gorkum T, et al. Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis 2001; 7: 855-861.
8. van Soolingen D, Qian L, de Haas P E, et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol 1995; 33: 3234-3238.
9. Marttila H J, Soini H, Eerola E, et al. A Ser315Thr substitution in katG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicrob Agents Chemother 1998; 42: 2443-2445.
10. Banerjee A, Dubnau E, Quemard A, et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994; 263: 227-230.
11. Ramaswamy S V, Reich R, Dou S J, et al. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2003; 47: 1241-1250.
12. Rattan A, Kalia A, Ahmad N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis 1998; 4: 195-209.
13. Cooksey R C, Morlock G P, Glickman S, Crawford J T. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol 1997; 35: 1281-1283.
14. De Beenhouwer H, Lhiang Z, Jannes G, et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tubercle Lung Dis 1995; 76: 425-430.
15. Miller L P, Crawford J T, Shinnick T M. The rpoB gene of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1994; 38: 805-811.
16. Telenti A, Imboden P, Marchesi F, et al. Detection of rifampicin resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341: 647-650.
17. Kokki M, Holmström P, Ruutu P. High sensitivity for tuberculosis in a national integrared surveillance system in Finland. Euro Surveill 2005; 10: 90-93.
18. Wayne L G, Krasnow I. Preparation of tuberculosis susceptibility testing mediums by means of impregnated disks. Am J Clin Pathol 1966; 45: 769-771.
19. van Doom H R, de Haas P E, Kremer K, Vandenbroucke-Grauls C M, Borgdorff M W, van Soolingen D. Public health impact of isoniazid-resistant Mycobacterium tuberculosis strains with a mutation at amino-acid position 315 of katG: a decade of experience in The Netherlands. Clin Microbiol Infect 2006; 12: 769-775.
20. EuroTB and the National Coordinators for Tuberculosis Surveillance in the WHO European Region. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2004. Saint-Maurice, France: Institut de Veille Sanitaire, 2006.
21. Espinal M A. The global situation of MDR-TB. Tuberculosis 2003; 83: 44-51.
22. Toungoussova O S, Sandven P, Mariandyshev A O, Nizovtseva N I, Bjune G, Caugant D A. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel oblast, Russia. J Clin Microbiol 2002; 40: 1930-1937.
23. Kubica T, Agzamova R, Wright A, et al. The Beijing genotype is a major cause of drug-resistant tuberculosis in Kazakhstan. Int J Tuberc Lung Dis 2005; 9: 646-653.
24. Lillebaek T, Andersen A B, Dirksen A, Glynn J R, Kremer K. Mycobacterium tuberculosis Beijing genotype. Emerg Infect Dis 2003; 9: 1553-1557.
25. Puustinen K, Marjamaki M, Rastogi N, et al. Characterization of Finnish Mycobacterium tuberculosis isolates by spoligotyping. J Clin Microbiol 2003; 41: 1525-1528.
26. Zhao J R, Bai Y J, Wang Y, Zhang Q H, Luo M, Yan X J. Development of a pyrosequencing approach for rapid screening of rifampicin, isoniazid and ethambutol-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2005; 9: 328-332.
27. Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S. Use of the GenoType MTBDR assay for rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2005; 43: 3699-3703.
28. Rossau R, Traore H, De Beenhouwer H, et al. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampicin. Antimicrob Agents Chemother 1997; 41: 2093-2098.
29. Rindi L, Bianchi L, Tortoli E, Lari N, Bonanni D, Garzelli C. Mutations responsible for Mycobacterium tuberculosis isoniazid resistance in Italy. Int J Tuberc Lung Dis 2005; 9: 94-97.
30. Hofling C C, Pavan E M, Giampaglia C M, et al. Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil. Int J Tuberc Lung Dis 2005; 9: 87-93.
31. Aktas E, Durmaz R, Yang D, Yang Z. Molecular characterization of isoniazid and rifampicin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey. Microb Drug Resist 2005; 11: 94-99.
32. Shemyakin I G, Stepanshina V N, Ivanov I Y, et al. Characterization of drug-resistant isolates of Mycobacterium tuberculosis derived from Russian inmates. Int J Tuberc Lung Dis 2004; 8: 1194-1203.
33. Hillemann D, Kubica T, Agzamova R, Venera B, Rüsch-Gerdes S, Niemann S. Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan. Int J Tuberc Lung Dis 2005; 9: 1161-1167.
34. Morlock G P, Plikaytis B B, Crawford J T. Characterization of spontaneous, in vitro-selected, rifampicin-resistant mutants of Mycobacterium tuberculosis strain H37Rv. Antimicrob Agents Chemother 2000; 44: 3298-3301.
35. Mariam D H, Mengistu Y, Hoffner S E, Andersson D I. Effect of rpoB mutations conferring rifampicin resistance on fitness of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2004; 48: 1289-1294.